-
公开(公告)号：US11957893B2
公开(公告)日：2024-04-16
申请号：US16947944
申请日：2020-08-25
申请人： Medtronic, Inc.
发明人： Brad C. Tischendorf , John E. Kast , Thomas P. Miltich , Gordon O. Munns , Randy S. Roles , Craig L. Schmidt , Joseph J. Viavattine , Christian S. Nielsen , Prabhakar A. Tamirisa , Anthony M. Chasensky , Markus W. Reiterer , Chris J. Paidosh , Reginald D. Robinson , Bernard Q. Li , Erik R. Scott , Phillip C. Falkner , Xuan K. Wei , Eric H. Bonde , David A. Dinsmoor , Duane L. Bourget , Forrest C M Pape , Gabriela C. Molnar , Joel A. Anderson , Michael J. Ebert , Richard T. Stone , Shawn C. Kelley , Stephen J. Roddy , Timothy J. Denison , Todd V. Smith
CPC分类号： A61N1/02 , A61B17/00234 , A61N1/05 , A61N1/0551 , A61N1/36007 , A61N1/3605 , A61N1/36057 , A61N1/36067 , A61N1/36071 , A61N1/36139 , A61N1/37205 , A61N1/37223 , A61N1/37235 , A61N1/37247 , A61N1/3727 , A61N1/3754 , A61N1/3756 , A61N1/3787 , A61N1/36021 , A61N1/36053 , A61N1/37211 , A61N1/37518 , F04C2270/0421
摘要： A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
-
公开(公告)号：US20200376256A1
公开(公告)日：2020-12-03
申请号：US16947945
申请日：2020-08-25
申请人： Medtronic, Inc.
发明人： Brad C. Tischendorf , John E. Kast , Thomas P. Miltich , Gordon O. Munns , Randy S. Roles , Craig L. Schmidt , Joseph J. Viavattine , Christian S. Nielsen , Prabhakar A. Tamirisa , Anthony M. Chasensky , Markus W. Reiterer , Chris J. Paidosh , Reginald D. Robinson , Bernard Q. Li , Erik R. Scott , Phillip C. Falkner , Xuan K. Wei , Eric H. Bonde
摘要： A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
-
公开(公告)号：US20190282818A1
公开(公告)日：2019-09-19
申请号：US16412069
申请日：2019-05-14
申请人： Medtronic, Inc.
发明人： Eric H. Bonde , John E. Kast , Erik R. Scott , Xuan K. Wei
摘要： In some examples, an implantable medical device includes an implantable housing, a neurostimulator within the housing, a plurality of electrodes, an implantable lead coupled to the housing, and an actuator formed with the housing. The implantable lead includes at least one electrode of the plurality of electrodes and one or more conductors coupling the at least one electrode to the neurostimulator. The actuator is configured to cause at least a portion of the implantable lead to deflect.
-
公开(公告)号：US10258789B2
公开(公告)日：2019-04-16
申请号：US14098608
申请日：2013-12-06
申请人： Medtronic, Inc.
发明人： Brad C. Tischendorf , Eric H. Bonde , Phillip C. Falkner , John E. Kast , Randy S. Roles , EriK R. Scott , Todd V. Smith , Xuan K. Wei , Anthony M. Chasensky , Michael J. Ebert , Shawn C. Kelley , Gabriela C. Molnar , Richard T. Stone
摘要： A medical device system for delivering a neuromodulation therapy includes a delivery tool for deploying an implantable medical device at a neuromodulation therapy site. The implantable medical device includes a housing, an electronic circuit within the housing, and an electrical lead comprising a lead body extending between a proximal end coupled to the housing and a distal end extending away from the housing and at least one electrode carried by the lead body. The delivery tool includes a first cavity for receiving the housing and a second cavity for receiving the lead. The first cavity and the second cavity are in direct communication for receiving and deploying the housing and the lead coupled to the housing concomitantly as a single unit.
-
公开(公告)号：US09931107B2
公开(公告)日：2018-04-03
申请号：US14098621
申请日：2013-12-06
申请人： Medtronic, Inc.
发明人： Brad C. Tischendorf , Eric H. Bonde , Phillip C. Falkner , John E. Kast , Randy S. Roles , Erik R. Scott , Todd V. Smith , Xuan K. Wei , Anthony M. Chasensky , Michael J. Ebert , Shawn C. Kelley , Gabriela C. Molnar , Richard T. Stone
CPC分类号： A61B17/00234 , A61N1/02 , A61N1/05 , A61N1/0551 , A61N1/36 , A61N1/36007 , A61N1/36021 , A61N1/3605 , A61N1/36053 , A61N1/36057 , A61N1/36067 , A61N1/36071 , A61N1/36139 , A61N1/37205 , A61N1/37211 , A61N1/37223 , A61N1/37235 , A61N1/37247 , A61N1/37252 , A61N1/3727 , A61N1/375 , A61N1/3754 , A61N1/3756 , A61N1/3787 , F04C2270/0421
摘要： A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
-
公开(公告)号：US09433783B2
公开(公告)日：2016-09-06
申请号：US14880066
申请日：2015-10-09
申请人： Medtronic, Inc.
发明人： Xuan K. Wei , Eric H. Bonde , Keith A. Miesel , Mark S. Lent , Gregory F. Molnar
CPC分类号： A61N1/36007 , A61N1/0514 , A61N1/0551 , A61N1/36128 , A61N1/36135 , A61N1/37235 , A61N1/37252
摘要： Techniques for managing urinary or fecal incontinence include delivering a first type of therapy to generate a first physiological response and, upon detecting a trigger event, delivering a second type of therapy to generate a second physiological response. The first type of therapy can be delivered on a substantially regular basis, while the second type of therapy is delivered as needed to provide an additional boost of therapy. The trigger event for activating the delivery of the second type of therapy may include input from a sensor that indicates a bladder condition, patient activity level or patient posture, or patient input. In some examples, the therapy is stimulation therapy.
-
公开(公告)号：US20150087896A1
公开(公告)日：2015-03-26
申请号：US14495002
申请日：2014-09-24
申请人： Medtronic, Inc.
IPC分类号： A61F2/00
CPC分类号： A61F2/0027 , A61F2/0018 , A61F2/0022
摘要： A urinary tract valve includes an expandable valve element positionable within a bladder of a patient via a urinary tract of the patient in a collapsed configuration. The expandable valve element is configured to transition from the collapsed configuration to an expanded configuration after being positioned within the bladder of the patient. The expandable valve element includes a ferromagnetic element that facilitates selective control of the expandable valve element with a magnetic field between an open position and a closed position when positioned within the bladder of the patient. In the closed position, the expandable valve element is configured to seal an internal urethral opening of the patient. In the open position, the expandable valve element is configured to allow urine to pass from the bladder of the patient, through an internal urethral opening of the patient and into a urethra of the patient.
摘要翻译： 泌尿道瓣膜包括可膨胀的阀元件，该可膨胀的阀元件可以通过处于折叠构造的患者的尿道定位在患者的膀胱内。 可膨胀阀元件构造成在定位在患者的膀胱内之后从折叠构型转变成扩张构型。 可膨胀阀元件包括铁磁元件，其在定位在患者的膀胱内时有助于在打开位置和关闭位置之间的磁场选择性地控制可膨胀阀元件。 在关闭位置，可膨胀阀元件构造成密封患者的内部尿道开口。 在打开位置，可膨胀阀元件构造成允许尿从患者的膀胱通过患者的内部尿道开口并进入患者的尿道。
-
公开(公告)号：US20130110201A1
公开(公告)日：2013-05-02
申请号：US13658278
申请日：2012-10-23
申请人： Medtronic, Inc.
发明人： Eric H. Bonde , Xuan K. Wei
IPC分类号： A61N1/36
CPC分类号： A61N1/375 , A61N1/36125 , A61N1/37229 , A61N1/37241 , A61N1/3752 , A61N1/3787
摘要： Devices, systems, and techniques for delivering trial stimulation therapy to a patient are disclosed. A trial neurostimulator (e.g., an IMD) may be implanted within a patient to deliver stimulation therapy during a relatively short trial period of time. This IMD may include limited circuitry and be powered by an external power source to minimize the size of the IMD within the patient. The IMD may include a non-hermetic housing capable of protecting the IMD circuitry for the trial period of time. In one example, the IMD may include a secondary coil configured to generate an electrical signal in response to a magnetic field generated by an external primary coil, circuitry configured to generate a stimulation signal in response to the electrical signal, and a non-hermetic implantable housing configured to encase or otherwise house the secondary coil and the circuitry.
摘要翻译： 公开了用于向患者递送试验刺激疗法的装置，系统和技术。 可以将试用神经刺激器（例如，IMD）植入患者体内以在相对较短的试验期内递送刺激疗法。 该IMD可以包括有限的电路并且由外部电源供电以最小化患者体内IMD的尺寸。 IMD可以包括能够在试用期间保护IMD电路的非密封外壳。 在一个示例中，IMD可以包括次级线圈，其被配置为响应于由外部初级线圈产生的磁场而产生电信号，电路被配置为响应于电信号产生刺激信号，以及非密封可植入 壳体被配置为包围或以其他方式容纳次级线圈和电路。
-
公开(公告)号：US20130110194A1
公开(公告)日：2013-05-02
申请号：US13658240
申请日：2012-10-23
申请人： Medtronic, Inc.
发明人： Xuan K. Wei
IPC分类号： A61N1/36
CPC分类号： A61N1/36171 , A61N1/0551 , A61N1/36071
摘要： In some examples, the disclosure relates to system, devices, and techniques for delivering electrical stimulation therapy to treat patient disorders characterized by overactive nerve activity. In one example, the stimulation therapy may include high frequency and low frequency stimulation. The high frequency stimulation may be configured to substantially block overactive pathological nerve activity of the patient and the combination of the high frequency and low frequency simulation may be configured to result in nerve activity that mimics non-pathological nerve activity.
摘要翻译： 在一些示例中，本公开涉及用于递送电刺激疗法以治疗以过度活跃的神经活动为特征的患者病症的系统，装置和技术。 在一个实例中，刺激疗法可以包括高频和低频刺激。 高频刺激可以被配置为基本上阻止患者的过度活跃的病理性神经活动，并且高频和低频模拟的组合可以被配置成导致模拟非病理性神经活动的神经活动。
-
公开(公告)号：US11969592B2
公开(公告)日：2024-04-30
申请号：US18193004
申请日：2023-03-30
申请人： Medtronic, Inc.
发明人： Lance Zirpel , Sudha B. Iyer , Xuan K. Wei
IPC分类号： A61N1/36
CPC分类号： A61N1/36007 , A61N1/36178
摘要： An implantable medical device (IMD) includes a memory configured to store a set of therapy parameters for subsensory electrical stimulation of a patient; and therapy delivery circuitry configured to deliver the subsensory electrical stimulation to at least one of a sacral nerve or tibial nerve based on the stored set of therapy parameters to provide immediate therapeutic effect caused by the ongoing delivery of the subsensory electrical stimulation to address incontinence, wherein a stimulation intensity of the subsensory electrical stimulation is less than 80% of a stimulation intensity at a sensory threshold, and wherein the patient does not perceive delivery of the subsensory electrical stimulation and perceives delivery of stimulation at the sensory threshold.
-
-
-
-
-
-
-
-
-
搜索结果
65 条记录 (耗时 0.204 秒)
